Pentixapharm Holding AG (VIE:PTPN)
1.488
+0.012 (0.81%)
At close: Dec 5, 2025
Pentixapharm Holding AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 6.97 | 23.23 | 9.7 | 1.09 | 2.39 |
| Short-Term Investments | - | - | 0.53 | - | - |
| Cash & Short-Term Investments | 6.97 | 23.23 | 10.23 | 1.09 | 2.39 |
| Cash Growth | -43.98% | 127.05% | 842.17% | -54.50% | - |
| Accounts Receivable | 0.02 | 6.81 | 0.16 | 0.51 | 0.01 |
| Other Receivables | 0.19 | 0.91 | 8.32 | 2.25 | 0.16 |
| Receivables | 0.2 | 7.71 | 8.48 | 2.77 | 0.17 |
| Other Current Assets | 1.87 | 0.34 | - | - | - |
| Total Current Assets | 9.04 | 31.28 | 18.71 | 3.85 | 2.56 |
| Property, Plant & Equipment | 0.24 | 0.27 | 0.32 | 0.33 | 0.26 |
| Long-Term Investments | - | - | - | - | 1.32 |
| Goodwill | - | - | 0.78 | 0.78 | - |
| Other Intangible Assets | 33.19 | 35.35 | 0.81 | 0.88 | 0.95 |
| Long-Term Deferred Tax Assets | - | - | 1.79 | 1.79 | - |
| Long-Term Deferred Charges | - | - | 50.98 | 46.23 | 24.06 |
| Other Long-Term Assets | 0.48 | 0.48 | 0.01 | 0.01 | - |
| Total Assets | 42.96 | 67.39 | 73.4 | 53.88 | 29.15 |
| Accounts Payable | 1.52 | 8.94 | 2.54 | 0.21 | 0.4 |
| Accrued Expenses | - | 0.6 | 0.35 | 0.3 | 0.07 |
| Current Income Taxes Payable | - | 0.08 | - | - | - |
| Current Unearned Revenue | - | 4.21 | 5.08 | - | - |
| Other Current Liabilities | 1.08 | 0.21 | 1.43 | 1.34 | 0.03 |
| Total Current Liabilities | 2.6 | 14.04 | 9.4 | 1.84 | 0.5 |
| Long-Term Debt | - | - | 6.3 | 6.11 | - |
| Long-Term Unearned Revenue | - | - | 0.34 | - | - |
| Long-Term Deferred Tax Liabilities | 3.64 | 3.93 | 8.88 | 7.45 | 0.76 |
| Other Long-Term Liabilities | 0 | 0 | 0 | 0 | - |
| Total Liabilities | 6.24 | 17.97 | 24.92 | 15.41 | 1.26 |
| Common Stock | 24.8 | 24.8 | 21.7 | 0.09 | 0.09 |
| Retained Earnings | -25.54 | -12.84 | 2.13 | -0.3 | -4.45 |
| Treasury Stock | -0.01 | -0.01 | - | - | - |
| Comprehensive Income & Other | 37.48 | 37.48 | 24.65 | 38.68 | 32.25 |
| Shareholders' Equity | 36.72 | 49.42 | 48.48 | 38.47 | 27.88 |
| Total Liabilities & Equity | 42.96 | 67.39 | 73.4 | 53.88 | 29.15 |
| Total Debt | - | - | 6.3 | 6.11 | - |
| Net Cash (Debt) | 6.97 | 23.23 | 3.93 | -5.03 | 2.39 |
| Net Cash Growth | -43.98% | 490.54% | - | - | - |
| Net Cash Per Share | 0.16 | 0.94 | 0.18 | - | - |
| Filing Date Shares Outstanding | 24.78 | 24.78 | 21.7 | - | - |
| Total Common Shares Outstanding | 24.78 | 24.78 | 21.7 | - | - |
| Working Capital | 6.44 | 17.24 | 9.31 | 2.01 | 2.06 |
| Book Value Per Share | 1.48 | 1.99 | 2.23 | - | - |
| Tangible Book Value | 3.53 | 14.06 | 46.9 | 36.81 | 26.94 |
| Tangible Book Value Per Share | 0.14 | 0.57 | 2.16 | - | - |
| Machinery | - | - | 0.48 | 0.44 | 0.33 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.